Cargando…

Plasma calprotectin as a biomarker of ultrasound synovitis in rheumatoid arthritis patients receiving IL-6 antagonists or JAK inhibitors

OBJECTIVES: To analyse the accuracy of plasma calprotectin in patients with rheumatoid arthritis (RA) receiving monoclonal antibodies against IL-6 receptors (anti-rIL-6) or JAK inhibitors (JAKis) in detecting ultrasound (US) synovitis and compare it with acute phase reactants [high-sensitivity C-rea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Frade-Sosa, Beatriz, Ponce, Andrés, Inciarte-Mundo, José, Morlà, Rosa, Ruiz-Esquide, Viginia, Macías, Laura, Azuaga, Ana Belen, Ramirez, Julio, Cañete, Juan D., Yague, Jordi, Auge, Josep M., Gomez-Puerta, José A., Sanmarti, Raimon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9486267/ https://www.ncbi.nlm.nih.gov/pubmed/36148395 http://dx.doi.org/10.1177/1759720X221114105

Ejemplares similares

From bench to bedside: Calprotectin (S100A8/S100A9) as a biomarker in rheumatoid arthritis
por: Inciarte-Mundo, José, et al.
Publicado: (2022)

Calprotectin and TNF trough serum levels identify power Doppler ultrasound synovitis in rheumatoid arthritis and psoriatic arthritis patients in remission or with low disease activity
por: Inciarte-Mundo, José, et al.
Publicado: (2016)

Calprotectin in Patients with Rheumatic Immunomediated Adverse Effects Induced by Checkpoints Inhibitors
por: Frade-Sosa, Beatriz, et al.
Publicado: (2023)

Analytical and clinical evaluation of DiaSorin Liaison® Calprotectin fecal assay adapted for serum samples
por: Macias‐Muñoz, Laura, et al.
Publicado: (2022)

High Sensitivity C Reactive Protein in Patients with Rheumatoid Arthritis Treated with Antibodies against IL-6 or Jak Inhibitors: A Clinical and Ultrasonographic Study
por: Frade-Sosa, Beatriz, et al.
Publicado: (2022)

Imaging Findings in Patients with Immune Checkpoint Inhibitor-Induced Arthritis
por: Ponce, Andrés, et al.
Publicado: (2022)

Calprotectin strongly and independently predicts relapse in rheumatoid arthritis and polyarticular psoriatic arthritis patients treated with tumor necrosis factor inhibitors: a 1-year prospective cohort study
por: Inciarte-Mundo, José, et al.
Publicado: (2018)

Immunopathologic characterization of ultrasound-defined synovitis in rheumatoid arthritis patients in clinical remission
por: Ramírez, Julio, et al.
Publicado: (2016)

Anti-carbamylated protein antibody isotype pattern differs between palindromic rheumatism and rheumatoid arthritis
por: Castellanos-Moreira, Raul, et al.
Publicado: (2020)

Differing specificities and isotypes of anti-citrullinated peptide/protein antibodies in palindromic rheumatism and rheumatoid arthritis
por: Cabrera-Villalba, Sonia, et al.
Publicado: (2017)

Patients with rheumatoid arthritis in clinical remission and ultrasound-defined active synovitis exhibit higher disease activity and increased serum levels of angiogenic biomarkers
por: Ramírez, Julio, et al.
Publicado: (2014)

Palindromic Rheumatism: Just a Pre-rheumatoid Stage or Something Else?
por: Sanmartí, Raimon, et al.
Publicado: (2021)

Differences in synovial fluid cytokine levels but not in synovial tissue cell infiltrate between anti-citrullinated peptide/protein antibody-positive and –negative rheumatoid arthritis patients
por: Gómez-Puerta, José A, et al.
Publicado: (2013)

Ectopic lymphoid neogenesis is strongly associated with activation of the IL-23 pathway in rheumatoid synovitis
por: Cañete, Juan D., et al.
Publicado: (2015)

Synovial Immunohistological Biomarkers of the Classification of Undifferentiated Arthritis Evolving to Rheumatoid or Psoriatic Arthritis
por: Cuervo, Andrea, et al.
Publicado: (2021)

Descriptive study of patients with uveitis attended during one-year period - diagnostic classification and treatment
por: Hernández, M V, et al.
Publicado: (2010)

The synovial and blood monocyte DNA methylomes mirror prognosis, evolution, and treatment in early arthritis
por: de la Calle-Fabregat, Carlos, et al.
Publicado: (2022)

Clinical Patterns and Follow-Up of Inflammatory Arthritis and Other Immune-Related Adverse Events Induced by Checkpoint Inhibitors. A Multicenter Study
por: Gómez-Puerta, José A., et al.
Publicado: (2022)

Psoriatic Arthritis: Pathogenesis and Targeted Therapies
por: Azuaga, Ana Belén, et al.
Publicado: (2023)

Serum calprotectin (S100A8/9): an independent predictor of ultrasound synovitis in patients with rheumatoid arthritis
por: Hurnakova, Jana, et al.
Publicado: (2015)

Anticitrullinated peptide antibodies (ACPA) in the serum of heavy smokers without arthritis - a differential role of associated pulmonary disease?
por: Ruiz-Esquide, V, et al.
Publicado: (2010)

Synovial lymphoid neogenesis is associated with IL-23 expression and disease activity in rheumatoid arthritis
por: Cañete, Juan D, et al.
Publicado: (2011)

Distinct synovial immunopathology in Behçet disease and psoriatic arthritis
por: Cañete, Juan D, et al.
Publicado: (2009)

Psoriatic Synovitis: Singularity and Potential Clinical Implications
por: Celis, Raquel, et al.
Publicado: (2019)

Withdrawal of infliximab therapy in ankylosing spondylitis in persistent clinical remission, results from the REMINEA study
por: Moreno, Mireia, et al.
Publicado: (2019)

Update on Cardiovascular Risk and Obesity in Psoriatic Arthritis
por: Ramírez, Julio, et al.
Publicado: (2021)

Synovial cytokine expression in psoriatic arthritis and associations with lymphoid neogenesis and clinical features
por: Celis, Raquel, et al.
Publicado: (2012)

Lower peripheral helper T cell levels in the synovium are associated with a better response to anti-TNF therapy in rheumatoid arthritis
por: Julià, Antonio, et al.
Publicado: (2020)

Immature Blood Vessels in Rheumatoid Synovium Are Selectively Depleted in Response to Anti-TNF Therapy
por: Izquierdo, Elena, et al.
Publicado: (2009)

The soluble biomarker calprotectin (a S100 protein) is associated to ultrasonographic synovitis scores and is sensitive to change in patients with rheumatoid arthritis treated with adalimumab
por: Hammer, Hilde Berner, et al.
Publicado: (2011)

Identification of robust and disease-specific stromal alterations in spondyloarthritis synovitis
por: Yeremenko, Nataliya, et al.
Publicado: (2011)

Diagnostic and prognostic value of antibodies against chimeric fibrin/filaggrin citrullinated synthetic peptides in rheumatoid arthritis
por: Sanmartí, Raimon, et al.
Publicado: (2009)

Upadacitinib for Patients with Rheumatoid Arthritis: A Comprehensive Review
por: Sanmartí, Raimon, et al.
Publicado: (2023)

Treat-To-Target and Treat-To-Budget in Rheumatoid Arthritis: Measuring the Value of Individual Therapeutic Interventions
por: Sacristán, José A., et al.
Publicado: (2019)

Impact of Comorbidities on Disease Activity, Patient Global Assessment, and Function in Psoriatic Arthritis: A Cross-Sectional Study
por: Lubrano, Ennio, et al.
Publicado: (2020)

Assessment of the Patient Acceptable Symptom State (PASS) in psoriatic arthritis: association with disease activity and quality of life indices
por: Lubrano, Ennio, et al.
Publicado: (2020)

Cost-effectiveness analysis of baricitinib versus adalimumab for the treatment of moderate-to-severe rheumatoid arthritis in Spain
por: Schlueter, Max, et al.
Publicado: (2019)

Predictive model to identify multiple failure to biological therapy in patients with rheumatoid arthritis
por: Novella-Navarro, Marta, et al.
Publicado: (2022)

Inhibition of the autocrine IL-6–JAK2–STAT3–calprotectin axis as targeted therapy for HR(−)/HER2(+) breast cancers
por: Rodriguez-Barrueco, Ruth, et al.
Publicado: (2015)

Development of a multiplex assay based on chimeric citrullinated peptides as proof of concept for diagnosis of rheumatoid arthritis
por: García-Moreno, Cristina, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_plsv4gvkcek6epgq702b9om46g